Taro Pharmaceutical Industries Ltd.

NYSE:TARO Voorraadrapport

Marktkapitalisatie: US$1.6b

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Taro Pharmaceutical Industries Beheer

Beheer criteriumcontroles 2/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Uday Baldota

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO6.8yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn8.8yrs
Gemiddelde ambtstermijn bestuur7.5yrs

Recente managementupdates

Recent updates

Taro Pharmaceutical Industries Ltd. Is An Overlooked Opportunity

Dec 12

Taro Pharmaceutical: Sun Pharma Deal Uncertain, No Discernible Value Beyond NAV (Rating Downgrade)

Aug 16

Taro Pharmaceutical: Potential Value In Sun Pharma Offer

Jun 02

Taro Pharmaceutical: Stagnating Growth At 1.6% Trailing Earnings Yield, Rate Hold

Feb 24

Taro Pharmaceutical GAAP EPS of $0.19 misses by $0.68, revenue of $139.2M misses by $23.92M

Jan 24

Taro Pharmaceutical Non-GAAP EPS of $0.66 misses by $0.18, revenue of $130.5M misses by $30.52M

Oct 28

Taro Pharmaceutical hits 52-week low; down 28% YTD

Aug 15

Taro Pharmaceutical Non-GAAP EPS of $1.09 beats by $0.24, revenue of $156.7M beats by $6.8M

Jul 27

Taro Pharmaceutical: 10%+ Projected Earnings Yield Is A Strong Calling Card

Jul 14

We Think Taro Pharmaceutical Industries' (NYSE:TARO) Healthy Earnings Might Be Conservative

Aug 03
We Think Taro Pharmaceutical Industries' (NYSE:TARO) Healthy Earnings Might Be Conservative

A Look At Taro Pharmaceutical Industries' (NYSE:TARO) Share Price Returns

Jan 26
A Look At Taro Pharmaceutical Industries' (NYSE:TARO) Share Price Returns

CEO

Uday Baldota (54 yo)

6.8yrs

Tenure

Mr. Uday V. Baldota has been Director at Association for Accessible Medicines. He has been the Chief Executive Officer of Taro Pharmaceutical Industries Ltd. since August 28, 2017 and served as its Co-Chie...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Uday Baldota
CEO & Director6.8yrsgeen gegevensgeen gegevens
William Coote
VP, CFO & Chief Accounting Officer2.5yrsgeen gegevensgeen gegevens
Itamar Karsenti
VP & Head of Operations9.5yrsgeen gegevensgeen gegevens
Avi Avramoff
VP and Head of R&D12.7yrsgeen gegevensgeen gegevens
Itzik Baruch
Vice President of Technical Services14.4yrsgeen gegevensgeen gegevens
Roman Kaplan
Vice President of Scientific and Technical Compliance Managerno datageen gegevensgeen gegevens
Erik Zwicker
VP, General Counsel & Secretary4.2yrsgeen gegevensgeen gegevens
Ara Aprahamian
Vice President of Sales & Marketing11.3yrsUS$616.14kgeen gegevens
Michele Visosky
VP & Head of Human Resourceno datageen gegevensgeen gegevens
Jayesh Shah
Head of Procurement12.5yrsgeen gegevensgeen gegevens
Richard Glaze
VP & Head of Information Technology8yrsgeen gegevensgeen gegevens
Ori Gutwerg
VP & Head of U.S. Generics Rx5.2yrsgeen gegevensgeen gegevens

8.8yrs

Gemiddelde duur

58yo

Gemiddelde leeftijd

Ervaren management: TARO's management team is seasoned and experienced (8.8 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Uday Baldota
CEO & Director7.5yrsgeen gegevensgeen gegevens
Dilip Shanghvi
Chairman of the Board10.9yrsUS$1.00mgeen gegevens
Robert Stein
Independent Director4.3yrsgeen gegevensgeen gegevens
Sudhir Valia
Director13.8yrsUS$500.00kgeen gegevens
James Kedrowski
Director13.1yrsgeen gegevensgeen gegevens
Linda Shushan
Independent Director7.5yrsgeen gegevensgeen gegevens
Abhay Gandhi
Vice Chairman7.5yrsgeen gegevensgeen gegevens
Oded Sarig
Independent Directorless than a yeargeen gegevensgeen gegevens

7.5yrs

Gemiddelde duur

68yo

Gemiddelde leeftijd

Ervaren bestuur: TARO's board of directors are considered experienced (7.5 years average tenure).